InvestorsHub Logo
Followers 29
Posts 1939
Boards Moderated 0
Alias Born 01/11/2011

Re: dr_lowenstein post# 24609

Saturday, 09/01/2012 4:17:05 PM

Saturday, September 01, 2012 4:17:05 PM

Post# of 410437
Good read. Thanks for posting that.

This was nice to see:

Guidance on development of abuse-resistant
formulations of opioids
– Provide regulatory guidance on development of
abuse-deterrent formulations and on post-marketing
assessment of their performance
– Many challenging scientific issues!
Incentivize product development
Avoid negative impact on Generics development
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News